Ulta Beauty, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ulta Beauty, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $12.39B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $11.30B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $11.21B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $10.21B | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $8.63B | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | $2.20B | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | $1.55B | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | $1.23B | Mar 26, 2021 |
| FY2020 | May 2, 2020 | $1.17B | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | $2.31B | Mar 26, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Feb 3, 2018 | $108.76M | Apr 3, 2018 |
| FY2017 | Oct 28, 2017 | $1.34B | Apr 3, 2018 |
| FY2017 | Jul 29, 2017 | $1.29B | Apr 3, 2018 |
| FY2017 | Apr 29, 2017 | $1.31B | Apr 3, 2018 |
| FY2017 | Jan 28, 2017 | $1.58B | Apr 3, 2018 |
| FY2017 | Oct 29, 2016 | $1.13B | Apr 3, 2018 |
| FY2017 | Jul 30, 2016 | $1.07B | Apr 3, 2018 |
| FY2017 | Apr 30, 2016 | $1.07B | Apr 3, 2018 |
| FY2016 | Jan 30, 2016 | $1.27B | Mar 28, 2017 |
| FY2016 | Oct 31, 2015 | $910.70M | Mar 28, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.15B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $1.20B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $1.29B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $1.24B | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $985.84M | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | $171.49M | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | $74.80M | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | $8.05M | Mar 26, 2021 |
| FY2020 | May 2, 2020 | ($78.51M) | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | $222.72M | Mar 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.53B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $1.56B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $1.68B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $1.64B | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $1.30B | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | $224.27M | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | $101.28M | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | $12.76M | Mar 26, 2021 |
| FY2020 | May 2, 2020 | ($101.48M) | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | $287.76M | Mar 26, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $7.00B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $6.00B | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | $5.71B | Mar 27, 2025 |
| FY2023 | Jan 28, 2023 | $5.37B | Mar 26, 2024 |
| FY2022 | Jan 29, 2022 | $4.76B | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $5.09B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $4.86B | Mar 26, 2021 |
| FY2019 | Feb 2, 2019 | $3.19B | Mar 27, 2020 |
| FY2018 | Feb 3, 2018 | $2.91B | Apr 2, 2019 |
| FY2017 | Jan 28, 2017 | $2.55B | Apr 3, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $4.20B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $3.51B | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | $3.43B | Mar 27, 2025 |
| FY2023 | Jan 28, 2023 | $3.41B | Mar 26, 2024 |
| FY2022 | Jan 29, 2022 | $3.23B | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $3.09B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $2.96B | Mar 26, 2021 |
| FY2019 | Feb 2, 2019 | $1.37B | Mar 27, 2020 |
| FY2018 | Feb 3, 2018 | $1.13B | Apr 2, 2019 |
| FY2017 | Jan 28, 2017 | $1.00B | Apr 3, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $2.80B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $2.49B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $2.28B | Mar 26, 2026 |
| FY2025 | Jan 28, 2023 | $1.96B | Mar 26, 2026 |
| FY2024 | Jan 29, 2022 | $1.54B | Mar 27, 2025 |
| FY2023 | Jan 30, 2021 | $2.00B | Mar 26, 2024 |
| FY2022 | Feb 1, 2020 | $1.90B | Mar 24, 2023 |
| FY2021 | Feb 2, 2019 | $1.82B | Mar 25, 2022 |
| FY2020 | Feb 3, 2018 | $1.77B | Mar 26, 2021 |
| FY2019 | Jan 28, 2017 | $1.55B | Mar 27, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 25 | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | 25 | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | 26 | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | 24 | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | 18 | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | 3 | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | 1 | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | 0 | Mar 26, 2021 |
| FY2020 | May 2, 2020 | (1) | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | 3 | Mar 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 25 | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | 25 | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | 26 | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | 24 | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | 17 | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | 3 | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | 1 | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | 0 | Mar 26, 2021 |
| FY2020 | May 2, 2020 | (1) | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | 3 | Mar 26, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $424.24M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $703.20M | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | $766.59M | Mar 27, 2025 |
| FY2023 | Jan 28, 2023 | $737.88M | Mar 26, 2024 |
| FY2022 | Jan 29, 2022 | $431.56M | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $1.05B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $392.33M | Mar 26, 2021 |
| FY2019 | Feb 2, 2019 | $409.25M | Mar 27, 2020 |
| FY2018 | Feb 3, 2018 | $277.45M | Apr 2, 2019 |
| FY2017 | Jan 28, 2017 | $385.01M | Apr 3, 2018 |